Voice Treatment for Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 19, 2018

Primary Completion Date

March 15, 2020

Study Completion Date

November 30, 2022

Conditions
Idiopathic Parkinson Disease
Interventions
BEHAVIORAL

Lee Silverman Voice Treatment

Persons with Parkinson's disease receive sixteen hours of voice treatment over a four week period. Participants will practice the vocal exercises at home for an additional four weeks.

DEVICE

SpeechVive

Persons with Parkinson's disease wear the SpeechVive device several hours a day over an eight week period during opportunities for communication.

BEHAVIORAL

Control

Persons assigned to the non-treatment control group will not participate in voice treatment.

Trial Locations (2)

47907

Purdue University, West Lafayette

01040

University of Massachusetts Amherst, Amherst

All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

collaborator

Purdue University

OTHER

lead

University of Massachusetts, Amherst

OTHER

NCT03700684 - Voice Treatment for Parkinson's Disease | Biotech Hunter | Biotech Hunter